Search

Conrad Lab publications

Skip to main content Cost Effectiveness of HCC screening We have conducted cost-effectiveness studies showing that screening is cost-effective compared to no screening. We have also shown that biomarker-based screening would be cost-effective, depending on utilization, costs of tests, and sensitivity…

Skip to main content HCC Risk Stratification and Precision Screening Although patients with cirrhosis are at high risk of HCC, there is variation in risk among individuals. We are collaborating with Dr. Hoshida at UT Southwestern to validate a novel blood-based signatures to help identify patients at…

Skip to main content HCC Screening Utilization and Interventions We have shown that despite clear guidelines, HCC screening remains underutilized. We have conducted multi-center survey studies to identify relevant barriers including provider knowledge gaps, patient misconceptions, and systemic ineffi…

Join Gao Lab

See photos of the Conrad Lab team

Meet the Rothermel Lab team.

Meet the Conrad Lab team

Conrad Lab news

Skip to main content Effectiveness of HCC Treatments Treatment strategies for HCC are evolving rapidly, with immunotherapy combinations showing promising results in large phase 3 clinical trials. However, effectiveness in clinical practice can differ from efficacy in trials given differences in patie…